Coronary

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

12 min.

Novel Solutions for High Bleeding Risk Patients

18 min.

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

9 min.

PCI vs CABG for LMCA Disease: Synthesis of the Literature

9 min.

Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions

7 min.

Immediate Non-Culprit Lesion PCI Is the Way to Go!

6 min.

Staged Non-Culprit Lesion PCI Is Safer and Better for the Patient!

10 min.

STEMI State-of-the-Art: A Physiology-Guided Strategy!

5 min.

STEMI State-of-the-Art: An Imaging-Guided Strategy!

8 min.

Case Presentation 2: SCAD Patient – How to Revascularize With PCI If You Have to

11 min.

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

8 min.

DCB Update: Overview of Current Clinical and Anatomical Indications

7 min.

Position 2: Ischemia and Viability Assessment Remain the Key to Guiding Revascularization

11 min.

Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management

7 min.

We Need More Data Following REVIVED: Unanswered Questions, Current and Future Trials

12 min.

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

14 min.

Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?

13 min.

State of the Art Left Main and Multivessel Revascularization in 2023: Where Does the Data Stand?

16 min.

Coronary Keynote Lecture: My Top Tips and Tricks for Saphenous Vein Graft Intervention

12 min.

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

13 min.

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

19 min.

Causes for Angina Without Obstructive Coronary Disease

10 min.

How Important Is Complete Revascularization?

7 min.

STEMI with Multivessel Disease: Managing the Non-Culprit Vesel

3 min.

ACS with a Large Thrombus Burden: Thrombectomy Revisited ? Guidelines Recommendations

3 min.

Thrombectomy Case Presentation

5 min.

Does It Matter What Stent I Use in a HBR Patient?

8 min.

We Should Be Offering More Surgery to Patients With Complex Multivessel Disease

10 min.

A Clinical Cardiologist’s View on How to Choose Revascularization Strategies

9 min.

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

7 min.

Coronary DCB in HBR Patients: An Alternative to DES?

6 min.

We Should Be Offering More PCI to Patients With Complex Multivessel Disease

5 min.

Complex and Higher Risk PCI: How Should It Be Defined and Who Should Be Doing It?

10 min.

Hard Outcomes Prevail

7 min.

Get With the Program: Patient-Oriented Outcomes Are Key

7 min.

Revascularization in LV Systolic Dysfunction: Revived or Dead?

12 min.

Management of Coronary Artery Disease in CLTI? Is That the Ticket?

7 min.